A novel bioassay to detect Nociceptin/Orphanin FQ release from single human polymorphonuclear cells.
Nociceptin/Orphanin FQ (N/OFQ) is the endogenous opioid agonist for the N/OFQ receptor or NOP. This receptor system is involved in pain processing but also has a role in immune regulation. Indeed, polymorphonuclear cells (PMNs) express mRNA for N/OFQ precursor and are a potential source for circulat...
Main Authors: | M F Bird, C P Hebbes, S W M Scott, J Willets, J P Thompson, D G Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0268868 |
Similar Items
-
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo.
by: Zoë L S Brookes, et al.
Published: (2013-01-01) -
Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain
by: Amal El Daibani, et al.
Published: (2022-01-01) -
The Role of Orphanin FQ/Nociceptin in Neuroplasticity: Relationship to Stress, Anxiety and Neuroinflammation
by: Elyse M Mallimo, et al.
Published: (2013-10-01) -
The Nociceptin/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass.
by: Jonathan P Thompson, et al.
Published: (2013-01-01) -
Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD
by: Zhang Yong, et al.
Published: (2012-10-01)